AppRank

Reviews: What People Think About AnticoagEvaluator

Cadiovention1

Rating: 2/5

Ios8 version does not work

SDCardioDoc

Rating: 1/5

Since updating to new risk models… the app doesn’t display and actual CHADs-Vasc Score. I understanding what you are going for, but this honestly makes the app less useful and no longer my go-to. Such a shame. Used it for many years and loved it prior to this change.

pkilaru

Rating: 1/5

It's become less functional since the IOS 8; you can no longer choose a therapy and see the details of its usefulness or the lack thereof. However, here is temporary workaround until they fix it: after selecting the risk factors for your patient, you click on the email icon and it will give you the relative risk reductions for all of the therapies. I know it's inelegant but is still functional. Hopefully, they will fix it soon.

About AnticoagEvaluator

Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for antithrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com

File size: 26390528

Launched countries: USAUCACNFRDEGBITJPKRRUDZAOARATAZBBBYBEBMBRBGCLCOCRHRCZDKDOECEGSVFIGHGRGTHKHUINIDIEILKZKEKWLBLTLUMOMGMYMXNLNZNGNOOMPKPAPEPHPLPTQAROSASGSKSIZAESLKSECHTWTHTNTRUAAEUYUZVEVNBOEELVNIPYKHMZYEBHCYMTBJBFCGJOLAMLSNTZUGZW